Filing Details

Accession Number:
0000899243-21-014857
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-05 17:05:50
Reporting Period:
2021-04-01
Accepted Time:
2021-04-05 17:05:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1809519 Goodrx Holdings Inc. GDRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1235685 Agnes Rey-Giraud C/O Goodrx Holdings, Inc.
2701 Olympic Boulevard
Santa Monica CA 90404
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-04-01 25,000 $0.00 25,000 No 4 C Indirect By ARG Family Legacy Trust #1
Class A Common Stock Disposition 2021-04-01 25,000 $40.01 0 No 4 S Indirect By ARG Family Legacy Trust #1
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By ARG Family Legacy Trust #1
No 4 S Indirect By ARG Family Legacy Trust #1
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Class B Common Stock Disposition 2021-04-01 25,000 $0.00 25,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
334,370 No 4 C Indirect
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.13, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027.